Wales Centre for Primary and Emergency Care Research (PRIME Centre Wales), Bangor, Wales.
Division of Population Medicine, Cardiff University, Cardiff, Wales.
Glob Health Res Policy. 2024 May 31;9(1):18. doi: 10.1186/s41256-024-00354-1.
The COVID-19 pandemic demonstrated the vital need for research to inform policy decision-making and save lives. The Wales COVID-19 Evidence Centre (WCEC) was established in March 2021 and funded for two years, to make evidence about the impact of the pandemic and ongoing research priorities for Wales available and actionable to policy decision-makers, service leads and the public.
We describe the approaches we developed and our experiences, challenges and future vision.
The centre operated with a core team, including a public partnership group, and six experienced research groups as collaborating partners. Our rapid evidence delivery process had five stages: 1. Stakeholder engagement (continued throughout all stages); 2. Research question prioritisation; 3. Bespoke rapid evidence review methodology in a phased approach; 4. Rapid primary research; and 5. Knowledge Mobilisation to ensure the evidence was available for decision-makers.
Between March 2021-23 we engaged with 44 stakeholder groups, completed 35 Rapid Evidence Reviews, six Rapid Evidence Maps and 10 Rapid Evidence Summaries. We completed four primary research studies, with three published in peer reviewed journals, and seven ongoing. Our evidence informed policy decision-making and was cited in 19 Welsh Government papers. These included pandemic infection control measures, the Action Plan to tackle gender inequalities, and Education Renew and Reform policy. We conducted 24 Welsh Government evidence briefings and three public facing symposia.
Strong engagement with stakeholder groups, a phased rapid evidence review approach, and primary research to address key gaps in current knowledge enabled high-quality efficient, evidence outputs to be delivered to help inform Welsh policy decision-making during the pandemic. We learn from these processes to continue to deliver evidence from March 2023 as the Health and Care Research Wales Evidence Centre, with a broader remit of health and social care, to help inform policy and practice decisions during the recovery phase and beyond.
新冠疫情大流行表明,研究对于为政策决策提供信息和拯救生命至关重要。威尔士 COVID-19 证据中心(WCEC)于 2021 年 3 月成立,获得为期两年的资金,以使有关该大流行影响和威尔士当前研究重点的证据可供政策决策者、服务负责人和公众使用和采取行动。
我们描述了我们开发的方法以及我们的经验、挑战和未来愿景。
该中心由一个核心团队运营,包括一个公共伙伴关系小组和六个有经验的研究小组作为合作伙伴。我们的快速证据提供过程有五个阶段:1. 利益相关者参与(在所有阶段持续进行);2. 研究问题的优先排序;3. 分阶段采用定制的快速证据审查方法;4. 快速进行初步研究;5. 知识传播,以确保证据可供决策者使用。
在 2021 年 3 月至 2023 年期间,我们与 44 个利益相关者团体进行了接触,完成了 35 项快速证据审查、6 项快速证据图和 10 项快速证据摘要。我们完成了四项主要研究,其中三项发表在同行评议期刊上,七项正在进行中。我们的证据为政策决策提供了信息,并被 19 份威尔士政府文件引用。其中包括大流行感染控制措施、解决性别不平等行动计划以及教育更新和改革政策。我们进行了 24 次威尔士政府证据简报和 3 次面向公众的研讨会。
与利益相关者团体的紧密接触、分阶段的快速证据审查方法以及针对当前知识空白的主要研究,使我们能够提供高质量、高效率的证据,以帮助在大流行期间为威尔士的政策决策提供信息。我们从这些过程中吸取经验教训,继续作为威尔士健康与保健研究证据中心从 2023 年 3 月起提供证据,扩大健康和社会保健的职权范围,以帮助在恢复阶段及以后为政策和实践决策提供信息。